Alumni Ventures

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).

Canid is a company focused on improving the vaccination process for pediatricians through innovative technology. It has developed a scanning system that streamlines the management of vaccination records by eliminating manual data entry and automatically uploading vaccine information into state registries. Additionally, Canid provides a dashboard and process tool that offers administrative consulting, automates vaccine workflows, and manages vaccine inventory. By enhancing the efficiency of vaccination record management, Canid enables pediatric practitioners and state officials to concentrate on their core responsibilities, ultimately facilitating better healthcare outcomes for children.

Centaur Labs is a provider of medical data annotation services that focuses on enhancing medical decision-making and diagnosis. The company operates a platform that leverages the collective intelligence of a global network of tens of thousands of students and professionals, who compete to deliver high-quality data annotation. By offering precise medical data labeling and analysis, Centaur Labs contributes to the development of advanced medical AI applications. This approach not only aids healthcare providers in making informed decisions but also aims to improve patient outcomes while reducing costs associated with healthcare.

Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.

Shape specializes in developing a 3D body scanning system that allows users to digitally measure and visualize their body composition in photorealistic detail. Utilizing advanced technologies such as artificial intelligence and computer vision, Shape provides accurate assessments of body metrics that traditional methods cannot capture, including regional volume and changes in body composition. The system offers personalized insights and guidance based on individual user data, helping users track fat loss and muscle gains in an engaging manner. By delivering fast and gamified feedback, Shape aims to transform how individuals approach their health and fitness goals, enhancing motivation and progress tracking.

ParcelBio is a biotechnology company specializing in the development of a novel, programmable method for safely and precisely delivering messenger RNA (mRNA) to diverse cell types within the body. Their technology aims to create targeted, potent, and durable RNA therapeutics, with the potential to treat a wide range of diseases, including cancer, genetic disorders, and infectious diseases.

Century Health is a healthcare technology company that enhances drug development and commercialization by utilizing artificial intelligence to harness otherwise inaccessible longitudinal clinical data. Its innovative platform connects with real-world, disease-specific datasets and employs AI to clean and standardize this information. This process eliminates data silos, allowing researchers to analyze real-world data more effectively and efficiently. By streamlining access to critical insights, Century Health aims to accelerate the pace of drug commercialization while upholding patient privacy and supporting the broader research community.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.

Alvee is a developer of an artificial intelligence-driven tool designed to enhance health equity and improve overall health outcomes. The company offers a solution that provides real-time, patient-specific alerts when health equity issues are identified for individual patients. By integrating social determinants of health, chronic conditions, demographic information, and risks associated with health inequity, Alvee's tool grants healthcare providers and payers a comprehensive view of a patient's health equity status. This approach not only assists in advancing health equity initiatives but also helps organizations fulfill data stratification quality reporting requirements effectively.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Emm is focused on creating advanced consumer health tools that enable individuals to manage their health according to their personal preferences. The company is developing a wearable device specifically designed to enhance reproductive health by providing biometric data. This data offers actionable insights into an individual's unique reproductive profile, allowing users and their healthcare providers to identify potential health issues and improve overall reproductive health outcomes. Emm aims to empower individuals by fostering a deeper understanding of their health through innovative technology and specialized knowledge.

Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.

Canid is a company focused on improving the vaccination process for pediatricians through innovative technology. It has developed a scanning system that streamlines the management of vaccination records by eliminating manual data entry and automatically uploading vaccine information into state registries. Additionally, Canid provides a dashboard and process tool that offers administrative consulting, automates vaccine workflows, and manages vaccine inventory. By enhancing the efficiency of vaccination record management, Canid enables pediatric practitioners and state officials to concentrate on their core responsibilities, ultimately facilitating better healthcare outcomes for children.

Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

3X Genetics is a company focused on developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company has created innovative technologies that allow for proactive screening of the population for conditions such as myotonic dystrophy and other trinucleotide repeat issues associated with progressive muscle weakness. By enabling healthcare professionals to detect these genetic disorders early, 3X Genetics plays a crucial role in preventing the birth of children affected by serious genetic diseases.

MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers a sales enablement software that integrates medical claims intelligence from both public and private payors, providing a user-friendly interface specifically designed for sales professionals and leaders. The platform delivers immediate insights into the addressable market within existing territories and facilitates understanding of market dynamics. By supplying comprehensive information on patient demographics, procedure volumes, referral patterns, and payment data, MedScout empowers its clients to optimize their sales strategies and enhance operational productivity, ultimately driving growth in the life sciences sector.

Train Fitness specializes in a workout tracking platform that utilizes artificial intelligence to automatically detect exercise sets and repetitions during strength training. By analyzing motion data from the Apple Watch, Train provides users with expertise-level insights into their workouts. This technology enables real-time coaching, allowing fitness enthusiasts to identify weaknesses, monitor their progress, and enhance their performance. The company's focus on automatic exercise detection positions it as a valuable resource for individuals looking to improve their fitness regimen.

MEND is a life sciences company dedicated to improving health outcomes through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that aid in healing from injuries, surgeries, and illness, as well as enhancing physical performance and addressing the challenges of aging. MEND's innovations have gained acceptance in various sectors, including hospitals, health systems, professional sports teams across major leagues, and elite military forces in the United States. The company's commitment to ongoing research and development positions it as a key player in the field of clinical nutritional products, aimed at enabling caregivers to support patients in achieving optimal health and recovery.

Pathfinder Health is a company that focuses on supporting the development of children aged 0-5 through an evidence-based clinical tool. This tool aids in monitoring child development milestones and offers guidance on how caregivers can effectively engage with children at various stages of their growth. By facilitating communication with healthcare professionals, the app promotes earlier diagnoses of developmental concerns. It also provides users with access to a wealth of resources, including evidence-based activities, articles, parenting tips, and local early intervention services. Through its innovative approach, Pathfinder Health empowers parents and caregivers to track their child's progress and identify potential developmental issues promptly.

Rensair is a developer of portable hospital-grade air purifiers designed to enhance indoor air quality in a variety of settings, including hospitals, schools, and care homes. The company employs advanced air purification technology that utilizes high-efficiency particulate air (HEPA13) filters combined with ozone-free ultraviolet light to effectively eliminate airborne viruses, including the coronavirus. Originally created for Scandinavian hospitals, Rensair's products are now trusted by businesses worldwide, providing a reliable solution for ensuring clean air in diverse environments.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Koala Health is a Boston-based company founded in 2021 that specializes in providing medications and health products tailored for pets. The company simplifies pet care by verifying and fetching prescriptions from veterinarians, sorting and packaging medications by date and time, and offering free delivery and refills. By focusing on vet-approved medications and supplements, Koala Health aims to enhance the quality of life for pets while easing the management of their health needs for pet owners.

PathSpot Technologies, Inc., established in 2017 and headquartered in New York City, specializes in food safety solutions. The company develops and manufactures a unique system that uses a proprietary algorithm to analyze fluorescent light, enabling it to scan employees' hands and detect pathogens that cause food-borne illnesses. This technology helps restaurants and their customers mitigate the risk of food-borne illnesses by providing instant, invisible signs of harmful bacteria and viruses.

Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By leveraging advancements in bioengineering and nanotechnology, Nanopath provides granular and clinically actionable information that allows for the sensitive and specific detection of viral, bacterial, and fungal pathogens. This innovative approach eliminates the need for nucleic acid amplification, thereby transforming traditional testing methodologies. The company's goal is to deliver high-quality molecular testing results in minutes, ultimately improving health outcomes for women.

Health Note is an AI chatbot platform based in San Francisco, California, founded in 2018. The company specializes in health data management, focusing on enhancing patient encounters by streamlining the collection of patient information. By sending an SMS link to patients, Health Note connects them to its AI-driven chatbot, which gathers pre-visit data and formats it into physician notes. This process simplifies documentation for healthcare providers and integrates seamlessly with existing electronic medical record systems, ensuring a frictionless experience without the need for app downloads or sign-ins. Health Note optimizes clinic workflows and encourages patient engagement in their own care.

Swing Therapeutics is focused on developing innovative digital therapeutics aimed at improving the lives of individuals with chronic conditions. The company assembles a team of scientists, clinicians, and technologists who collaborate with leading researchers to create evidence-based treatments. These digital solutions are designed to empower patients, allowing them to manage their health more effectively and regain control over their illnesses. By providing transformative therapeutic options, Swing Therapeutics seeks to enhance the overall well-being of patients, enabling them to lead healthier and more fulfilling lives.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Oobli is a food company focused on developing innovative protein sweeteners derived from exotic plants. These unique sweeteners offer a delicious taste while significantly reducing calories, making them a healthier alternative to traditional sugars. Produced through fermentation, Oobli's sweeteners have no glycemic impact and do not influence the gut microbiome, allowing consumers to enjoy sweetness without concerns related to blood sugar, insulin, or weight management. The company has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for multiple protein sources, which positions it as a leader in the healthy sweetener market. By transforming flavors, Oobli aims to enhance everyday food experiences while promoting better health outcomes for its users.

NeuraLight is a venture focused on improving the lives of individuals affected by neurological disorders through innovative digital solutions. The company has developed a digital neurology platform that leverages a proprietary, de-identified oculometric database. This technology allows for the precise evaluation of patients using standard smartphones or webcams, enabling clinicians to effectively differentiate between healthy individuals and those with neurological conditions. Additionally, the platform facilitates the stratification of various patient subgroups and the monitoring of disease progression, enhancing the overall approach to neurological care. Through its efforts, NeuraLight aims to advance the understanding and treatment of neurological disorders, benefiting billions of individuals worldwide.

Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.

Rensair is a developer of portable hospital-grade air purifiers designed to enhance indoor air quality in a variety of settings, including hospitals, schools, and care homes. The company employs advanced air purification technology that utilizes high-efficiency particulate air (HEPA13) filters combined with ozone-free ultraviolet light to effectively eliminate airborne viruses, including the coronavirus. Originally created for Scandinavian hospitals, Rensair's products are now trusted by businesses worldwide, providing a reliable solution for ensuring clean air in diverse environments.

Health Hero, Inc. is a wellness technology company that specializes in developing a custom wellness platform aimed at enhancing employee well-being across various industries globally. Founded in 2014 and headquartered in Tampa, Florida, the company offers a range of wellness options, including health risk assessments, cultural assessments, and biometric screenings, which can be accessed through mobile devices and computers. Health Hero's platform integrates gamification elements to engage employees by allowing them to earn points, badges, and rewards for completing tasks and reaching milestones. With a user reach exceeding five million and support for over 14,000 companies and communities, Health Hero effectively stores more than five billion health data points, positioning itself as a leader in the well-being sector.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.

Kinsa, Inc., established in 2012 and headquartered in San Francisco, develops smart thermometers that connect to both Android and iOS devices. These thermometers facilitate communication with individuals who are ill, providing them with care information and enabling data collection to map and track health trends in real-time, thereby aiding in disease spread prevention.

Insiteflow is a company based in Austin, Texas, founded in 2018 by Anthony Gerardi and Corey Hall. It specializes in providing an electronic health record (EHR) integrated platform designed to enhance clinical decision-making and workflow management for healthcare practitioners. The platform offers point-of-care insights that facilitate improved decision-making and treatment planning for patients. By deploying patent-pending technology, Insiteflow optimizes EHR workflows, thereby increasing user adoption and operational efficiency. Additionally, it enables the documentation of clinical decisions within EHR databases, allowing healthcare professionals to drive improvements directly at the point of care and during critical decision-making processes.

Gordy Health is a virtual care provider based in Pasadena, California, founded in 2021. The company specializes in blood pressure management to reduce patients' risk of heart attack, stroke, and kidney failure. Gordy Health offers a healthcare platform that allows users to manage their blood pressure from home, with features including direct access to heart specialists, easy-to-schedule virtual appointments, real-time diagnostics, prescription delivery, and ongoing monitoring and medication adjustments. The goal is to prevent complications from high blood pressure, helping patients achieve healthier lives and increased longevity.

Olaris is a biotechnology company focused on transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. Founded in 2013 and headquartered in Framingham, Massachusetts, Olaris aims to enhance precision medicine by utilizing the body’s natural communication systems to identify biomarkers essential for treatment responsiveness. Through its myOLARIS™ precision diagnostics pipeline, the company collaborates with healthcare providers to tailor therapeutic approaches, thereby optimizing patient outcomes and minimizing adverse effects. Olaris is dedicated to advancing personalized healthcare solutions that improve the efficacy of medical interventions.

GritWell Ltd is a digital health platform that specializes in addressing chronic health conditions through a holistic approach. Founded in 2018 and based in San Francisco, the company connects patients with a variety of health professionals, including nutritionists, health coaches, and naturopathic doctors. GritWell's platform facilitates secure video consultations, direct messaging, and online scheduling, allowing for personalized treatment plans and credible advice tailored to individual needs. By focusing on root cause treatment rather than mere symptom management, GritWell employs clinically validated symptom assessments to guide patients toward appropriate care while integrating natural treatment options. This innovative approach aims to improve health outcomes by enabling patients to find practitioners who can address the underlying issues of their chronic symptoms, such as insomnia, migraines, and anxiety.

Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.

AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.

Moons is a healthcare technology company based in Mexico City, specializing in orthodontic and dental hygiene products. Founded in 2019, the company offers innovative dental services that allow customers to straighten their teeth using transparent aligners instead of traditional braces. Moons creates individualized 3D models of patients' teeth, enabling specialists to design tailored treatment plans. Clients visit Moons Studios for consultations with qualified orthodontists, and subsequently receive a set of personalized clear aligners by mail. The average treatment time is approximately six months, during which patients can achieve a straighter and whiter smile at an affordable cost. Moons also provides dental services online in Mexico and Colombia.

SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.

Insiteflow is a company based in Austin, Texas, founded in 2018 by Anthony Gerardi and Corey Hall. It specializes in providing an electronic health record (EHR) integrated platform designed to enhance clinical decision-making and workflow management for healthcare practitioners. The platform offers point-of-care insights that facilitate improved decision-making and treatment planning for patients. By deploying patent-pending technology, Insiteflow optimizes EHR workflows, thereby increasing user adoption and operational efficiency. Additionally, it enables the documentation of clinical decisions within EHR databases, allowing healthcare professionals to drive improvements directly at the point of care and during critical decision-making processes.

Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.

FULLFILL is a digital health platform that focuses on providing evidence-based corporate health programs aimed at improving employee well-being and reducing medical expenses for companies. Founded in 2019 and headquartered in Los Angeles, FULLFILL partners with employers to deliver virtual health coaching that addresses chronic conditions such as obesity, diabetes, and mental health issues. The program is conducted entirely online and features a wealth of resources, including videos, podcasts, articles, and interactive tools, supported by trained Master Coaches available 24/7. FULLFILL has demonstrated significant success, achieving high employee engagement and enrollment rates, and has reported improved health outcomes compared to traditional programs. With a strong emphasis on long-term results and a money-back guarantee, FULLFILL aims to address the increased health challenges faced by employees, particularly in the wake of COVID-19, while also serving as a valuable retention tool for employers.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.

SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

Brio Systems, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in COVID-19 testing solutions for workplaces. Its comprehensive platform offers on-site PCR and antibody testing, logistical support, medical oversight, and digital results communication within three days. Brio connects labs and medical suppliers with employers, serving industries such as manufacturing and food processing. The company's turnkey solution includes laboratory testing, collection kit fulfillment, test requisitioning, medical supervision, and digital reporting, supporting up to 50,000 tests daily. Brio's platform ensures data security through SMS authentication, enabling employers to make informed, data-driven decisions to protect their workforce.

Oobli is a food company focused on developing innovative protein sweeteners derived from exotic plants. These unique sweeteners offer a delicious taste while significantly reducing calories, making them a healthier alternative to traditional sugars. Produced through fermentation, Oobli's sweeteners have no glycemic impact and do not influence the gut microbiome, allowing consumers to enjoy sweetness without concerns related to blood sugar, insulin, or weight management. The company has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for multiple protein sources, which positions it as a leader in the healthy sweetener market. By transforming flavors, Oobli aims to enhance everyday food experiences while promoting better health outcomes for its users.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Better Life Partners Inc. is a healthcare company based in Hanover, New Hampshire, dedicated to providing comprehensive support for individuals struggling with opioid use disorder in the United States. Established in 2018, the company offers a range of services, including medication-assisted treatment, counseling, peer coaching, and group sessions. Better Life Partners focuses on delivering personalized healthcare to vulnerable populations, utilizing technology to create customizable care plans that ensure effective and reliable service delivery. By integrating medical and behavioral healthcare, the company addresses the needs of those affected by addiction, facilitating their recovery through a combination of telehealth, community-based support, and innovative care approaches. With additional offices across New Hampshire, Better Life Partners aims to make a meaningful impact on the lives of individuals seeking to overcome substance abuse challenges.

Brio Systems, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in COVID-19 testing solutions for workplaces. Its comprehensive platform offers on-site PCR and antibody testing, logistical support, medical oversight, and digital results communication within three days. Brio connects labs and medical suppliers with employers, serving industries such as manufacturing and food processing. The company's turnkey solution includes laboratory testing, collection kit fulfillment, test requisitioning, medical supervision, and digital reporting, supporting up to 50,000 tests daily. Brio's platform ensures data security through SMS authentication, enabling employers to make informed, data-driven decisions to protect their workforce.

Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.

Moons is a healthcare technology company based in Mexico City, specializing in orthodontic and dental hygiene products. Founded in 2019, the company offers innovative dental services that allow customers to straighten their teeth using transparent aligners instead of traditional braces. Moons creates individualized 3D models of patients' teeth, enabling specialists to design tailored treatment plans. Clients visit Moons Studios for consultations with qualified orthodontists, and subsequently receive a set of personalized clear aligners by mail. The average treatment time is approximately six months, during which patients can achieve a straighter and whiter smile at an affordable cost. Moons also provides dental services online in Mexico and Colombia.

Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.

Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

Olaris is a biotechnology company focused on transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. Founded in 2013 and headquartered in Framingham, Massachusetts, Olaris aims to enhance precision medicine by utilizing the body’s natural communication systems to identify biomarkers essential for treatment responsiveness. Through its myOLARIS™ precision diagnostics pipeline, the company collaborates with healthcare providers to tailor therapeutic approaches, thereby optimizing patient outcomes and minimizing adverse effects. Olaris is dedicated to advancing personalized healthcare solutions that improve the efficacy of medical interventions.

Kenshō Health is a Los Angeles-based health company that operates online, emphasizing a whole-person approach that integrates mind, body, and spirit. Founded by experienced entrepreneurs Krista Berlincourt and Danny Steiner, Kenshō combines scientific research with personalization technology to simplify holistic health care. The company offers an on-demand wellness service booking platform that connects users with verified wellness providers across various specialties, including acupuncture, massage, yoga, naturopathy, and meditation. By enabling individuals to easily find and book wellness professionals, Kenshō aims to support a balanced and healthy lifestyle without the need for in-person visits.

E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018, that focuses on developing rapid diagnostic tests for epidemic fever viruses. The company designs paper-based diagnostic systems and kits that facilitate the detection of viruses such as dengue, chikungunya, and Zika. E25Bio's innovative platform enables multiplexed testing that quickly identifies viral antigens during infections, allowing for real-time data reporting through a mobile application. This capability supports epidemiologic predictions and disease mapping, empowering governments and health organizations to respond effectively to outbreaks and manage public health crises. Through its commitment to fast, mobile testing solutions, E25Bio aims to prevent severe health outcomes associated with viral epidemics.

Brave Care, Inc. specializes in urgent pediatric health care services, providing treatment for a wide range of conditions such as allergies, asthma, cough, ear pain, eye problems, fever, minor fractures, and more. The company also offers pediatric-specific laboratory services and on-site x-ray facilities. Founded in 2019 and headquartered in Portland, Oregon, Brave Care operates primary and urgent care clinics designed exclusively for children in Oregon and Texas. In addition to in-person care, Brave Care provides pediatric advice to parents through its website and mobile app, supporting families nationwide in promoting their children's well-being.

Mahmee is an integrated care delivery platform focused on maternal and infant health. It aims to bridge critical gaps in the U.S. healthcare system, which faces high maternity costs and mortality rates, particularly among Black mothers and infants. By providing a digital infrastructure, Mahmee connects patients, independent health professionals, and large healthcare organizations to enhance access to comprehensive prenatal and postpartum care. The platform features a care management system that links health records for mothers and their babies, identifying clinical risks and facilitating collaboration among maternity and infant care practitioners. This enables healthcare providers to share care plans effectively, ensuring coordinated care. Additionally, Mahmee's marketplace allows new and expecting parents to discover community-based perinatal health providers and access care quickly, both in-person and virtually.

Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.

AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.

Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.

Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

Mitra Biotech, established in 2010, is a biotechnology company based in Woburn, Massachusetts, with a laboratory office in Bengaluru, India. It specializes in personalized cancer treatment, offering a novel functional assay called CANScript. This assay replicates a patient's tumor microenvironment, measures multiple parameters, and converts them into a single score predicting clinical response to selected therapies. Mitra Biotech's technology aids biopharma companies in drug discovery and development, expanding access to personalized medicine and enhancing cancer treatment selection.

AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.

Apprentice Health is a predictive analytics firm focused on enhancing the efficiency of healthcare systems by providing targeted interventions. Founded by Rajiv Sivendran and Artur Menzeleev and based in Boston, Massachusetts, the company develops a comprehensive operations platform aimed at increasing patient access, improving the patient experience, and reducing clinical staff burnout. By analyzing current workflows, Apprentice Health identifies inefficiencies and offers actionable recommendations to optimize scheduling, staffing, and facility utilization. This approach not only aims to elevate patient and staff satisfaction but also to lower operational costs, ultimately enabling healthcare providers to serve more patients effectively.

Higia Technologies, founded in 2016 and based in Mexico City, specializes in developing EVA, a non-invasive wearable device aimed at assessing breast cancer risk. This innovative device features tactile sensors that map the surface of the breast and its surrounding areas. By continuously monitoring changes in breast temperature, size, and weight through embedded biosensors, EVA empowers women to actively track their breast health. The company's focus is on making breast cancer risk assessment more accessible and user-friendly.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Bainbridge Health, Inc. is a Philadelphia-based company founded in 2016 that specializes in developing a clinical intelligence and data analytics platform aimed at enhancing medication safety in hospital settings. The company's offerings include a vendor-agnostic medication safety platform that streamlines data management, reducing the reliance on manual data clerking and ad-hoc reporting. Their solutions, designed for medication safety leaders and hospital safety professionals, include an infusion pump management software known as InfusionWare, which centralizes infusion data to improve patient safety and effectively manage pump information. By mitigating medication errors, Bainbridge Health's platform helps healthcare providers reduce avoidable costs and improve overall patient care.

SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

RubiconMD, Inc. is a healthcare technology company that offers an online platform facilitating communication between primary care clinicians and specialists through eConsults. Founded in 2013 and headquartered in New York, RubiconMD enables primary care providers to quickly seek guidance and opinions on medical cases, thereby enhancing patient care and reducing costs. The platform allows clinicians to identify specialists based on various criteria, such as ratings and experience, ensuring informed decision-making in patient management. Additionally, RubiconMD provides continuing medical education (CME) programs, including live and on-demand webinars, and features RubiconRx, a clinical pharmacy service that supports medication management for patients. The company serves a diverse clientele, including employers, community health centers, health plans, and direct primary care practices, and also offers services related to electronic health records, workflow integration, and clinician engagement.

SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.

DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.

AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.

Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Established in 2013, the company specializes in the development of innovative electrosurgical devices aimed at enhancing surgical procedures. One of its key products is Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device. This device utilizes bipolar current to create a controlled zone of ablation during surgery, facilitating the coagulation and ablation of soft tissue beds. Sira's unique design features a saline microinfusion system that ensures optimal contact with target tissue, allowing it to be seamlessly integrated with existing electrosurgical generators in operating rooms. This makes Sira an accessible and effective option for surgeons seeking to improve intraoperative ablation techniques.

RubiconMD, Inc. is a healthcare technology company that offers an online platform facilitating communication between primary care clinicians and specialists through eConsults. Founded in 2013 and headquartered in New York, RubiconMD enables primary care providers to quickly seek guidance and opinions on medical cases, thereby enhancing patient care and reducing costs. The platform allows clinicians to identify specialists based on various criteria, such as ratings and experience, ensuring informed decision-making in patient management. Additionally, RubiconMD provides continuing medical education (CME) programs, including live and on-demand webinars, and features RubiconRx, a clinical pharmacy service that supports medication management for patients. The company serves a diverse clientele, including employers, community health centers, health plans, and direct primary care practices, and also offers services related to electronic health records, workflow integration, and clinician engagement.

ActiveProtective is a consumer device company that produces smart garments to reduce traumatic injury using wearable airbag technology. The company's proprietary technology uses 3D motion sensors to determine the stereotypical motions and accelerations that govern the body’s normal, daily activities, in order to determine ’departures’ from what is allowable. This technique called "fall disambiguation", allows users to determine falls prior to impact, intercept hip fractures, and protect themselves from risks during sports and military sessions by deploying micro-airbag protection. ActiveProtective was founded in 2006 and is based in Allentown, Pennsylvania.

Lumiata Inc. is a company specializing in predictive health analytics tailored for risk-bearing organizations. Founded in 2013 and based in San Mateo, California, Lumiata utilizes a medical graph that systematically organizes and analyzes a vast array of data points, facilitating real-time predictive analytics for hospital networks and insurance carriers. This technology provides insights into symptoms, diagnoses, procedures, and medications, allowing healthcare providers to enhance patient care efficiency. The company's flagship product, The Lumiata Risk Matrix, offers personalized predictions regarding individual health changes and their timeline, grounded in a robust chain of medical reasoning. Lumiata's platform leverages over 120 million patient records, integrating advanced machine learning tools and pre-trained models to support various applications such as underwriting and care management. By combining big data with clinical expertise, Lumiata empowers healthcare organizations to manage risks and costs effectively while ensuring privacy for individual members.

Celularity is a clinical-stage biotechnology company focused on advancing cellular medicine through the development of off-the-shelf placental-derived allogeneic cell therapies. Its product pipeline includes unmodified and genetically modified natural killer (NK) cells, CAR-engineered T cells, and mesenchymal-like adherent stromal cells. The company targets various health conditions, including cancer, immunologic disorders, infectious diseases, and degenerative illnesses. Celularity leverages the unique biology of the placenta, aiming to create effective and accessible therapies to address significant unmet medical needs. In addition to its cell therapy initiatives, Celularity operates a bio-banking segment, which contributes substantially to its revenue.

Iris Plans, Inc. is a technology-driven company that offers advance care planning (ACP) services tailored for individuals facing serious medical conditions. Founded in 2015 and based in Austin, Texas, the company utilizes a telehealth platform to connect healthcare professionals with patients and their families, facilitating the creation of personalized healthcare plans to guide critical medical decisions. Iris Plans provides a range of services, including the completion of living will documents, medical power of attorney arrangements, and directives to physicians, all customized to meet the legal requirements of each state. The company emphasizes the importance of ACP by highlighting its benefits, which include improved quality of care, reduced stress for families, increased satisfaction, and lower healthcare costs. Iris Plans serves customers across the United States, striving to alleviate the burdens associated with serious medical conditions through comprehensive and accessible planning solutions.

Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Established in 2013, the company specializes in the development of innovative electrosurgical devices aimed at enhancing surgical procedures. One of its key products is Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device. This device utilizes bipolar current to create a controlled zone of ablation during surgery, facilitating the coagulation and ablation of soft tissue beds. Sira's unique design features a saline microinfusion system that ensures optimal contact with target tissue, allowing it to be seamlessly integrated with existing electrosurgical generators in operating rooms. This makes Sira an accessible and effective option for surgeons seeking to improve intraoperative ablation techniques.

Kinsa, Inc., established in 2012 and headquartered in San Francisco, develops smart thermometers that connect to both Android and iOS devices. These thermometers facilitate communication with individuals who are ill, providing them with care information and enabling data collection to map and track health trends in real-time, thereby aiding in disease spread prevention.

Iris Plans, Inc. is a technology-driven company that offers advance care planning (ACP) services tailored for individuals facing serious medical conditions. Founded in 2015 and based in Austin, Texas, the company utilizes a telehealth platform to connect healthcare professionals with patients and their families, facilitating the creation of personalized healthcare plans to guide critical medical decisions. Iris Plans provides a range of services, including the completion of living will documents, medical power of attorney arrangements, and directives to physicians, all customized to meet the legal requirements of each state. The company emphasizes the importance of ACP by highlighting its benefits, which include improved quality of care, reduced stress for families, increased satisfaction, and lower healthcare costs. Iris Plans serves customers across the United States, striving to alleviate the burdens associated with serious medical conditions through comprehensive and accessible planning solutions.